We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Intera Oncology® Inc. has reintroduced Hepatic Artery Infusion (HAI) therapy to the market after its discontinuation in 2018 by the prior manufacturer dismayed patients and physicians. Hepatic Artery Infusion
Medtronic has secured a CE mark for its Affera Mapping and Ablation System, comprising Sphere-9 Catheter and Affera Prism-1 Mapping Software, to treat atrial arrhythmias. Affera system is
Dutch medical technology company Prolira has secured the Food and Drug Administration (FDA) 510(k) approval for its DeltaScan Brain State Monitor. Prolira is a spin-off of the University
Doctors in the U.S. can now access a novel NAD+ blood diagnostic for their patients. This is thanks to the launch of a new partnership with epigenetic laboratory TruDiagnostic and Finland-based
Visby Medical has received the US Food and Drug Administration 510(k) approval and CLIA waiver for its second-generation Sexual Health point of care (POC) test for women. The
Swiss medicine software company SOPHiA GENETICS has partnered with consumer electronics company Agilent Technologies to provide a solution for cancer analysis. Under the partnership, SOPHiA will integrate its
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the Gibraltar Health Authority, today announced they have signed a long-term strategic partnership continuing their
US-based precision oncology company Guardant Health has submitted an application to the US Food and Drug Administration (FDA), seeking premarket approval (PMA) for its Shield cancer test. Shield
A new study by Hospital for Special Surgery (HSS) researchers showed positive results for the minimally invasive procedure MISB for treating bunion in people with asymptomatic flatfoot. The
Archer Materials Limited (“Archer”, the “Company”, “ASX: AXE”) is pleased to inform shareholders that the Company has progressed the development of its biochip technology by electronically controlling the